waiver or variance filed on behalf of Myrtho Branch, M.D., Najib Kirmani, M.D., James Reed, M.D., IMPOWER, Inc., from Rule 64B8-9.0141, F.A.C., with regard to the prohibition against the prescribing of non-narcotic controlled substances such as ...  

  •  

    DEPARTMENT OF HEALTH

    Board of Medicine

    RULE NO.:RULE TITLE:

    64B8-9.0141Standards for Telemedicine Practice

    NOTICE IS HEREBY GIVEN that on September 9, 2014, the Board of Medicine, received a petition for waiver or variance filed on behalf of Myrtho Branch, M.D., Najib Kirmani, M.D., James Reed, M.D., IMPOWER, Inc., from Rule 64B8-9.0141, F.A.C., with regard to the prohibition against the prescribing of non-narcotic controlled substances such as Vyvanse, Adderall, Concerta, Ritalin, Strattera, Focalin and other similar classes of stimulant medications prescribed for the treatment of ADHD, ADD and other mental health disorders through the use of telemedicine. Comments on this petition should be filed with the Board of Medicine, 4052 Bald Cypress Way, Bin #C03, Tallahassee, Florida 32399-3053, within 14 days of publication of this notice.

    A copy of the Petition for Variance or Waiver may be obtained by contacting: Allison M. Dudley, J.D., Executive Director, Board of Medicine, at the above address or telephone: (850)245-4131.

Document Information

Contact:
Allison M. Dudley, J.D., Executive Director, Board of Medicine, at the above address, or telephone (850) 245-4131.
Related Rules: (1)
64B8-9.0141. Standards for Telemedicine Practice